BCR-ABL Mutations in Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors and Impact on Survival-Reference-Cited by-同舟云学术

BCR-ABL Mutations in Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors and Impact on Survival

Published:2015-08-17 Issue:9 Volume:33 Page:451-458
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Pagnano Katia Borgia Barbosa,Bendit Israel,Boquimpani Carla,De Souza Carmino Antonio,Miranda Eliana C M,Zalcberg Ilana,Larripa Irene,Nardinelli Luciana,Silveira Rosana Antunes,Fogliatto Laura,Spector Nelson,Funke Vaneuza,Pasquini Ricardo,Hungria Vania,Chiattone Carlos Sérgio,Clementino Nelma,Conchon Monika,Moiraghi Elena Beatriz,Lopez Jose Luis,Pavlovsky Carolina,Pavlovsky Miguel A.,Cervera Eduardo E,Meillon Luis Antonio,Simões Belinda,Hamerschlak Nelson,Bozzano Alicia Helena Magarinos,Mayta Ernesto,Cortes Jorge,Bengió Raquel M,

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/07357907.2015.1065499

Reference27 articles.

1. Part I: Mechanisms of resistance to imatinib in chronic myeloid leukaemia

2. Several Bcr-Abl kinase domain mutants associated with imatinib mesylate resistance remain sensitive to imatinib

3. Cause and management of therapy resistance

4. Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia

5. Activity of Bosutinib, Dasatinib, and Nilotinib Against 18 Imatinib-Resistant BCR/ABL Mutants

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ABL Kinase Domain Mutations in Iranian Chronic Myeloid Leukemia Patients with Resistance to Tyrosine Kinase Inhibitors;Laboratory Medicine;2020-08-21

2. Mutations in the BCR‑ABL1 kinase domain in patients with chronic myeloid leukaemia treated with TKIs or at diagnosis;Oncology Letters;2020-05-20

3. Single nucleotide polymorphism in PTEN-Long gene: A risk factor in chronic myeloid leukemia;Gene;2019-04

4. Towards modern anticancer agents that interact with tubulin;European Journal of Pharmaceutical Sciences;2019-04

5. Mutations in the breakpoint cluster region-Abelson murine leukemia 1 gene in Brazilian patients with chronic myeloid leukemia;Hematology, Transfusion and Cell Therapy;2018-10